{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-076761","form_type":"8-K","ticker":"REVB","cik":"0001810560","company_name":"REVELATION BIOSCIENCES, INC.","filed_at":"2024-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.255073+00:00","generated_at":"2026-06-01T02:32:24.345536+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Revelation Biosciences adjusts warrant exercise price to $2.39 per share","bullets":["Class C warrants now exercisable for 1/30th of a common share at $2.39 per share.","Class D warrants now exercisable for one common share at $2.39 per share.","Cede & Co. cannot process exercises at adjusted price until DTC system updates.","Warrant holders may exercise by sending Notice to Continental Stock Transfer with DWAC instructions."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-076761","json":"https://secwatch.observer/filing/0000950170-24-076761.json","markdown":"https://secwatch.observer/filing/0000950170-24-076761.md","text":"https://secwatch.observer/filing/0000950170-24-076761.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810560/000095017024076761/0000950170-24-076761-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810560/000095017024076761/revb-20240624.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:32:24.345536+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}